Despite the growth in technologies for preventative healthcare, the discovery of promising biomarkers, gene variants etc, there is a problem in translating these advances into benefits for the patient. Early detection of associations between biomarkers, genes, nutrition and medication is offered by the existing system and result in earlier, more effective and simpler interventions that are usually based on nutritional and exercise modifications rather than medication. Increased emphasis is placed on preventative healthcare and delaying the onset of chronic complex diseases such as type II Diabetes and CVD. These diseases are caused by a combination of genetic and environmental factors, the former immutable but the latter amenable to modification with the aim of prevention. The service will screen pre-symptomatic, higher risk patients (e.g. hypertensive), and will identify through genetics and environmental analysis the preventative interventions to reduce risk factor levels, patients will be given diet/lifestyle advice and will be prescribed suitable medication where appropriate. The overall aim of EuroGENE is to validate in the European market the existing service as well as to enhance both its security and user friendliness.